000			03743nam a2200445 a 4500
001			EBC703863
003			MiAaPQ
005			20240120132534.0
006			m o d |
007			cr cn|||||||||
008			760408s1976 ne a sb 111 0 eng d
010			_z 76010396
020			_z0444152059 (Amer. Elsevier)
020			_z9021940442 (Excerpta Medica)
020			_z9780470663318
020			_a9780470717899 (electronic bk.)
035			_a(MiAaPQ)EBC703863
035			_a(Au-PeEL)EBL703863
035			_a(CaPaEBR)ebr10575452
035			_a(CaONFJC)MIL369395
035			_a(OCoLC)797918355
040			_aMiAaPQ _cMiAaPQ _dMiAaPQ
050		4	_aQP603.M6 _bS95 1975
082	0	4	_a612/.0151/8 _222
111	2		_aSymposium on Monoamine Oxidase and its Inhibition _d(1975 : _cLondon, England)
245	1	0	_aMonoamine oxidase and its inhibition _h[electronic resource] : _bin honour of Mary L. C. Bernheim.
260			_aAmsterdam ; _aNew York : _bElsevier/Excerpta Medica/North-Holland, _c1976.
300			_axii, 415 p. : _bill.
490	1		_aCiba Foundation symposium ; 39 (new ser.)
504			_aIncludes bibliographical references and indexes.
505	0		_aKety, S.S. Introduction.--Tipton, K. F., Houslay, M.D., and Mantle, T.J. The nature and locations of the multiple forms of monamine oxidase.--Maycock, A.L. et al. The action of acetylenic inhibitors on mitochondrial monoamine oxidase: structure of the flavin site in the inhibited enzyme.--Salach, J.I. et al. Cysteinyl flavin in monamine oxidase from the central nervous system.--Gorkin, V.Z. Monoamine oxidase inhibitors and the transformation of monoamine oxidases.--Sourkes, T.L. and Missala, K. Nutritional requirements for amine metabolism in vivo.--Youdim, M.B.H. and Holzbauer, M. Physiological aspects of the oxidative deamination of monoamines.--Knoll, J. Analysis of the pharmacological effects of selective monoamine oxidase inhibitors.--Neff, N.H. and Fuentes, J.A. The use of selective monoamine oxidase inhibitor drugs for evaluating pharmacological and physiological mechanisms.--Trendelenburg, U., Graefe, K.H., and Henseling, M. The part played by monoamine oxidase in the inactivation of catecholamines in intact tissues.--Sharman, D.F. Can the intra- and extra-homoneuronal metabolism of catecholamines be distinguished in the mammalian central nervous system?--Green, A.R. and Youdim, M.B.H. Use of a behavioural model to study the action of monoamine oxidase inhibition in vivo.--Maitre, L., Delini-Stula, A., and Waldmeier, P.C. Relations between the degree of monoamine oxidase inhibition and some psychopharmacological responses to monoamine oxidase inhibitors in rats.--Pare, C.M.B. Introduction to clinical aspects of monoamine oxidase inhibitors in the treatment of depression.--Roth, M. et al. The relationship between classification and response to drugs in affective disorders--problems posed by drug response in affective disorders.--Sandler, M. Variations in monoamine oxidase activity in some human disease states.--Murphy, D.L. Clinical, genetic, hormonal and drug influences on the activity of human platelet monoamine oxidase activity in schizophrenia and schizo-affective psychosis.
533			_aElectronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
650		0	_aMonoamine oxidase _vCongresses.
650		0	_aMonoamine oxidase _xInhibitors _vCongresses.
655		4	_aElectronic books.
700	1		_aBernheim, Molly, _d1902-1997.
710	2		_aProQuest (Firm)
830		0	_aCiba Foundation symposium ; _vnew ser. 39.
856	4	0	_uhttps://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=703863 _zClick to View
999			_c65173 _d65173